• POSTER
  Lopinavir and efavirenz concentrations in paired hair samples as a marker of cumulative exposure among postpartum
  women and breastfeeding infants in Tororo, Uganda
  J. Mwesigwa, D. Cohan, A. Plenty, et al
  Poster     Abstract
• Cell-free HIV1 RNA load remains low in milk among HIV1-infected mothers presenting a T CD4 lymphocytes count
  above 350 cells per µl and an undetectable plasmatic viral load seven days postpartum up to 10 months of breastfeeding
  J. Konaté, C.W.M. Nadembega, H.A. Traoré, et al
  Abstract
• The incidence of the hypertriglyceridemic waist phenotype in a randomized prospective
  comparison between atazanavir/ritonavir (ATV/r) and lopinavir/ritonavir (LPV/r) each in
  combination with tenofovir DF/emtricitabine (TDF/FTC) in antiretroviral naive HIV
  G. Moyle, W. Hu, R. Wang , et al
  Abstract
  Cell-free HIV1 RNA load remains low in milk among HIV1-infected mothers presenting a T CD4 lymphocytes count above
  350 cells per µl and an undetectable plasmatic viral load seven days postpartum up to 10 months of breastfeeding
  J. Konaté, C.W.M. Nadembega, H.A. Traoré, et al
  Abstract
• Comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral (ARV)
  experienced Colombian HIV patients: a 2011 economic and quality adjusted life year (QALY) analysis
  K. Simpson, R. Baran, S. Kirbach, et al
  Abstract
• Low-level viremia between 50 and 200 copies/mL was not associated with confirmed viral load rebound in HIV+ patients
  initiated on LPV/r-based HAART: data from the multi-center STAR/STELLA cohorts
  E. Wolf, A. Baumgarten, B. Bieniek, et al
  Abstract
• Absence of clinically relevant drug interaction between delamanid, a new drug for multidrug-resistant tuberculosis
  (MDR-TB) and tenofovir
   or lopinavir/ritonavir in healthy subjects
  A. Paccaly , C. Petersen , S. Patil, et al
  Abstract
• Pediatric neurodevelopmental functioning following in utero exposure to triple-NRTI versus PI-based ART in a randomized trial, Botswana
  B. Kammerer, D. Kacane, G. Mayondi, et al
  Abstract
• Changing patterns of NRTI and PI resistance mutations between 2006 and 2011 in >1,200 ART-experienced
  South African patients: association with the introduction of tenofovir (TDF) and abacavir (ABC) and
  with the cumulative effects of LPV/r therapy
  G. van Zyl, M. Claassen, S. Engelbrecht, et al
  Abstract
   

XIX International AIDS Conference